Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Layer Thickness Monitoring in Multi-Layer Tablets – V 2.0

Posted on By

Tablets: SOP for Layer Thickness Monitoring in Multi-Layer Tablets – V 2.0

Standard Operating Procedure for Layer Thickness Monitoring in Multi-Layer Tablets

Department Quality Control
SOP No. SOP/TAB/134/2025
Supersedes SOP/TAB/134/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for monitoring the layer thickness of multi-layer tablets during production to ensure uniformity and meet the required specifications for tablet performance and quality.

2. Scope

This SOP applies to the monitoring of layer thickness in multi-layer tablets during the manufacturing process. It ensures that each layer of the tablet is within the specified thickness range, contributing to consistent tablet quality.

3. Responsibilities

  • Quality Control (QC): Responsible for monitoring and measuring the layer thickness of multi-layer tablets during production, ensuring that the thickness meets the required specifications.
  • Tablet Compression Operator: Responsible for ensuring that the compression process is carried out correctly and that layer thickness is maintained within the specified limits.
  • Quality Assurance (QA): Ensures that the layer thickness monitoring procedure is followed and reviews the results for compliance with the specified standards.

4. Accountability

The QC Manager is accountable for ensuring that layer thickness measurements are taken correctly and consistently throughout

production. The QA Manager is responsible for reviewing the results and ensuring compliance with the required quality standards.

See also  Tablets: SOP for Optimizing Coating Suspension Viscosity - V 2.0

5. Procedure

5.1 Layer Thickness Measurement

  1. Measure the thickness of the tablet layers at regular intervals during the compression process.
  2. Use precision calipers or other appropriate measuring devices to measure the thickness of each layer in the multi-layer tablet. Each layer must be measured at multiple points around the tablet to ensure uniformity.
  3. Record the measurement of each layer separately, noting the average thickness and any variations.
  4. The thickness of each layer should be within the specified tolerance range, typically ± 0.05 mm, depending on the product specifications.

5.2 Sampling

  1. For every batch, collect a representative sample of tablets to measure the layer thickness. Typically, collect 10 tablets per batch to ensure accurate representation.
  2. For multi-layer tablets, measure both the individual layers and the overall tablet thickness to verify the correct formation of all layers.
  3. Ensure that the sample is taken from different locations (top, middle, and bottom of the batch) to evaluate consistency across the entire batch.

5.3 Monitoring Frequency

  1. Monitor the layer thickness at regular intervals during the compression process. This could be after every 100 tablets or at specific stages of production (e.g., after each layer is applied).
  2. If the layer thickness consistently falls within the specified tolerance, monitoring can be reduced to once every 500 tablets. However, if there is a variation in the results, increase the monitoring frequency to every 50 tablets.
See also  Tablets: SOP for Strip Packing Process for Coated Tablets - V 2.0

5.4 Corrective Actions

  1. If the layer thickness falls outside the specified tolerance range, take corrective actions such as adjusting the compression force, modifying the filling volume, or altering the tablet press settings.
  2. After making adjustments, re-sample and re-test the tablets to ensure that the layer thickness is within specification.
  3. Document all corrective actions taken and the results of re-sampling in the batch record (Annexure-2).

5.5 Documentation

  1. Record the layer thickness measurements for each tablet sampled, including the average thickness and the individual layer measurements, in the batch record (Annexure-2).
  2. Document any deviations from the specified thickness range and the corrective actions taken in the deviation report (Annexure-1).
  3. Ensure that all records are signed, dated, and reviewed by QA for compliance with the required specifications.

5.6 Acceptance Criteria

  1. The thickness of each layer should fall within the specified tolerance limits, typically ± 0.05 mm, unless otherwise specified for a specific product.
  2. If the layer thickness exceeds the allowable tolerance, the batch may need to be rejected or reworked.

5.7 Post-Production Actions

  1. Once the layer thickness has been confirmed to meet specifications, proceed with the next steps of tablet processing, such as coating, drying, and packaging.
  2. Ensure that the equipment used for measuring layer thickness is calibrated regularly and maintained according to the preventive maintenance schedule.
See also  Tablets: SOP for Risk Assessment in Tablet Manufacturing Processes - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <1217> – Tablet Thickness and Uniformity Testing
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Tablet Layer Specifications

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Layer thickness exceeded tolerance limit Adjusted compression force and granule size John Doe

Annexure-2: Batch Record

Sample Number Layer Thickness Result Action Taken
Sample 1 Pass (Layer thickness within tolerance) Accepted

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated layer thickness monitoring process Improved quality standards QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Capsule: SOP for Preparing Liquids for Soft Gelatin Capsules – V 2.0
Next Post: Ointments: SOP for Requalification of Key Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version